WHO welcomes data on COVID-19 in China
WHO Director-General Dr Tedros Adhanom Ghebreyesus spoke with Minister Ma Xiaowei, director of China's National Health Commission, about the COVID-19 situation in the country. WHO appreciates this meeting, as well as the public release of information on the overall situation.
Chinese officials provided information to WHO and in a press conference on a range of topics, including outpatient clinics, hospitalizations, patients requiring emergency treatment and critical care, and hospital deaths related to COVID-19 infection.
WHO is analysing this information, which covers early December 2022 to 12 January 2023, and allows for a better understanding of the epidemiological situation and the impact of this wave in China. WHO requested that this type of detailed information continue to be shared with us and the public. WHO notes the efforts by Chinese authorities to scale up clinical care for its population at all levels, including in critical care.
The overall epidemiology—reflecting a rapid and intense wave of disease caused by known sub-variants of Omicron with higher clinical impact on older people and those with underlying conditions—is similar to waves of infection experienced by other countries, as is the increased pressure on health services. The reported data indicate a decline in case numbers, hospitalizations, and those requiring critical care. WHO has requested a more detailed breakdown of data by province over time.
While the Chinese Center for Disease Control and Prevention has earlier reported that Omicron sublineages BA.5.2 and BF.7 are currently circulating, WHO continues to ask that further sequences be shared with open access databases such as GISAID for deeper phylogenetic analyses, and for continued collaboration with technical groups working on virus evolution, clinical care, and beyond.
WHO will continue to work with China, providing technical advice and support, and engaging on analysing the situation. On the call today, Dr. Tedros also reiterated the importance of China's deeper cooperation and transparency on understanding the origins of the COVID-19 pandemic, and in carrying out the recommendations detailed in the report of the Strategic Advisory Group for the Origins of Novel Pathogens.
Related Items:China, clinics, COVID-19, disease, doing business in middle east, Health, hospitalizations, middle east article news, middle east business development, middle east business economy, patients, WHO
Notice: It seems you have Javascript disabled in your Browser. In order to submit a comment to this post, please write this code along with your comment: 266ae265bd49b02ec9eaf5b40fd959fb
Medlab to address the US$7 billion Middle East and Africa
Global NFT Sales Slumped 76% YoY to $638M in December
Global NFT Sales Slumped 76% YoY to $638M in December The once-booming NFT market...
Crashing markets result in a record number of crypto heists in history
Crashing markets result in a record number of crypto heists in history Besides a...
SAP Collaborations Champion Young Voices to Inspire a Sustainable Climate Movement
SAP Collaborations Champion Young Voices to Inspire a Sustainable Climate Movement In line with...
Nash fintechX launches CNet0, an integrated technology-driven carbon offset marketplace
Nash fintechX launches CNet0, an integrated technology-driven carbon offset marketplace CNet0 enables organizations to...
Top Nine Workplace Predictions for CHROs in 2023 Gartnar: As workplace volatility continues in...
Flexible working hours can benefit work-life balance, businesses and productivity
Flexible working hours can benefit work-life balance, businesses and productivity (ILO News) – Reduced...